A detailed history of Twinbeech Capital LP transactions in Boston Scientific Corp stock. As of the latest transaction made, Twinbeech Capital LP holds 149,477 shares of BSX stock, worth $13.6 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
149,477
Previous 113,965 31.16%
Holding current value
$13.6 Million
Previous $8.78 Million 42.73%
% of portfolio
0.25%
Previous 0.18%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$72.96 - $84.0 $2.59 Million - $2.98 Million
35,512 Added 31.16%
149,477 $12.5 Million
Q2 2024

Aug 14, 2024

BUY
$67.33 - $77.71 $7.67 Million - $8.86 Million
113,965 New
113,965 $8.78 Million
Q2 2023

Aug 14, 2023

BUY
$49.72 - $54.64 $34.9 Million - $38.3 Million
701,082 New
701,082 $37.9 Million
Q4 2022

Feb 14, 2023

BUY
$39.56 - $47.22 $1.41 Million - $1.69 Million
35,711 Added 168.54%
56,900 $2.63 Million
Q3 2022

Nov 14, 2022

SELL
$36.71 - $109.66 $3.58 Million - $10.7 Million
-97,425 Reduced 82.14%
21,189 $821,000
Q2 2022

Aug 15, 2022

SELL
$35.24 - $47.1 $8.71 Million - $11.6 Million
-247,190 Reduced 67.57%
118,614 $4.42 Million
Q1 2022

May 16, 2022

BUY
$40.9 - $45.1 $15 Million - $16.5 Million
365,804 New
365,804 $16.2 Million
Q3 2021

Nov 15, 2021

SELL
$41.23 - $45.88 $3.17 Million - $3.52 Million
-76,777 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$38.58 - $44.24 $2.96 Million - $3.4 Million
76,777 New
76,777 $3.28 Million
Q4 2020

Feb 16, 2021

SELL
$33.15 - $41.97 $1.98 Million - $2.51 Million
-59,874 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$34.44 - $42.23 $1.54 Million - $1.89 Million
-44,825 Reduced 42.81%
59,874 $2.29 Million
Q2 2020

Aug 14, 2020

BUY
$30.19 - $39.11 $2.24 Million - $2.9 Million
74,222 Added 243.53%
104,699 $3.68 Million
Q1 2020

May 15, 2020

BUY
$25.83 - $45.71 $787,220 - $1.39 Million
30,477 New
30,477 $994,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Twinbeech Capital LP Portfolio

Follow Twinbeech Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Twinbeech Capital LP with notifications on news.